Is this not the pertinent quote from the article:
'Bioshares analyst Mark Pachacz, who still covers the stock, says the Pfizer bid is a “fair, reasonable bid given challenges lie ahead in commercialising this technology, highlighted by recent clinical trial results showing further work needed on algorithm”.'
RAP media thread., page-3319
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #